Get In Touch

Angiotensin converting enzyme inhibitors are a group of drugs used for the treatment of heart failure, high blood pressure (hypertension), or decrease complications of myocardial infarction (heart attack). These drugs are also useful in slowing down kidney disease progression in patients with chronic kidney disease or kidney disease in diabetic patients. The mechanism of action of angiotensin converting enzyme inhibitors is to decrease the amount of angiotensin II produced. Angiotensin II has an effect on the body to increase pressure in the kidney, blood volume, and blood pressure.

Angiotensin converting enzyme inhibitors widen the blood vessels by lowering the amount of angiotensin II in the body. These also increase the amount of urine produced by kidneys. This results in lowering of pressure in the kidney, lowering blood volume, and blood pressure. There is a drop in aldosterone and noradrenalin levels due to inhibition of angiotensin II by angiotensin converting enzyme inhibitors which helps in reducing blood pressure. Angiotensin converting enzyme inhibitors also increases bradykinin which widens the blood vessels, thereby decreasing blood pressure. These also cause a few side effects depending upon which type of angiotensin converting enzyme inhibitors are taken. Side effects include swelling of face or airways (angioedema), reduced kidney function, dizziness, high potassium levels (hyperkalemia), dry cough, and low blood pressure (hypotension).

Increase in prevalence of high blood pressure is the major factor driving the angiotensin converting enzyme inhibitors market. According to the World Health Organization, over 1 in 5 adults suffer from high blood pressure globally. Complications of high blood pressure cause approximately 9.4 million deaths across the world each year. Rise in prevalence of heart failure also propels the angiotensin converting enzyme inhibitors market. According to the Centers for Disease Control and Prevention (CDC), approximately 5.7 million adults in the U.S. suffer from heart failure each year, nearly half of these people die within five years of diagnosis.

The global angiotensin converting enzyme inhibitors market can be segmented based on disease type, dosage form, and distribution channel. In terms of disease type, the Angiotensin Converting Enzyme Inhibitors market can be divided into heart failure, high blood pressure (hypertension), heart attack, and kidney disease. Based on dosage form, the global angiotensin converting enzyme inhibitors market can be categorized into oral tablets and oral solution. Based on distribution channel, the angiotensin converting enzyme inhibitors market can be classified into online pharmacies, retail pharmacies, and hospital pharmacies.

Geographically, the global angiotensin converting enzyme inhibitors market can be segmented into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the largest angiotensin converting enzyme inhibitors market share in 2016. Rise in prevalence of heart failure, heart attack, and high blood pressure drive the angiotensin converting enzyme inhibitors market in the region. Europe held the second largest market share in 2016. Increase in prevalence of kidney disease and high blood pressure in the region fuel the growth of the market in the region. The angiotensin converting enzyme inhibitors market in Asia Pacific is anticipated to be driven by increase in government initiatives for the health care sector especially in countries such as India and China. The global angiotensin converting enzyme inhibitors market in Middle East & Africa is anticipated to be driven by initiatives taken by the governments in the health care sector. The angiotensin converting enzyme inhibitors market in Latin America is anticipated to experience strong growth during the forecast period owing to the government initiatives for heart diseases in the region.

Key players in the global angiotensin converting enzyme inhibitors market include Bristol-Myers Squibb Company, Par Pharmaceutical Companies, Inc., UCB, Inc., Pfizer, Inc., and AstraZeneca.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Angiotensin Converting Enzyme Inhibitors Market